Kybora
European Pharma Group Proposes TEE Voucher System to Revitalize Antibiotics R&D

European Pharma Group Proposes TEE Voucher System to Revitalize Antibiotics R&D

10 12 月, 2024
News
Executive Summary – The Europe…
READ MORE
European Pharma Group Proposes TEE Voucher System to Revitalize Antibiotics R&D

European Pharma Group Proposes TEE Voucher System to Revitalize Antibiotics R&D

10 12 月, 2024
News
Executive Summary – …
READ MORE
KYBORA Advises Xbrane on Global Licensing Agreement with Intas

KYBORA Advises Xbrane on Global Licensing Agreement with Intas

5 12 月, 2024
News
KYBORA, a leading gl…
READ MORE
Navigating Priority Review Voucher Eligibility: Beyond Rare Pediatric Disease Designation

Navigating Priority Review Voucher Eligibility: Beyond Rare Pediatric Disease Designation

4 12 月, 2024
News
Executive Summary&nb…
READ MORE
Banner

Understanding the Role of the Not Same Active Moiety Principle in RPDD and PRV Evaluations

2 12 月, 2024
News
Executive Summary&nb…
READ MORE
The latest trends on biotech companies with negative enterprise values

The Latest Trends on Biotech Companies with Negative Enterprise Values: Insights and Implications

13 8 月, 2024
News
In the post Covid er…
READ MORE
KYBORA Advises Lupin

KYBORA Advises Lupin on the Divestiture of U.S. Commercial Women’s Health Specialty Business to Evofem

1 8 月, 2024
News
Global pharma major …
READ MORE
Foundation Rwanda

KYBORA’s Charitable Work

26 6 月, 2024
News
The Stories of Secon…
READ MORE

Join KYBORA At BIO 2024

28 5 月, 2024
News
Join KYBORA at BIO 2…
READ MORE

Foundation Rwanda Update

18 4 月, 2024
Uncategorized
KYBORA’s Charitable …
READ MORE

Wishing Our Clients, Partners And Friends In China A Happy New Year!

8 2 月, 2024
News
The KYBORA Team wish…
READ MORE

KYBORA Releases A Chinese Version Of Its Website To Accelerate Its Growth In Asia

15 11 月, 2023
News
KYBORA releases a Ch…
READ MORE

The Impact of the Inflation Reduction Act (IRA) on Orphan Drugs

27 9 月, 2023
News
Sept. 27, 2023 - The…
READ MORE

TYPE & ENTER: